| |
 |
Editorial [Hot Topic: Cyclooxygenase-2 Inhibitors and Cancer (Guest Editor: J.-P. Henichart)]
 |
| |
|
pp.185-185 (1) Author: Jean-Pierre Henichart |
| |
|
|
| |
|
Mechanisms Leading to COX-2 Expression and COX-2 Induced Tumorigenesis: Topical Therapeutic Strategies Targeting COX-2 Expression and Activity
|
| |
|
pp.187-208 (22) Authors: Aurelie Telliez, Christophe Furman, Nicole Pommery, Jean-Pierre Henichart |
| |
|
|
| |
|
The Potential and Rationale for COX-2 Inhibitors in Lung Cancer
|
| |
|
pp.209-220 (12) Authors: Kostyantyn Krysan, Karen L. Reckamp, Sherven Sharma, Steven M. Dubinett |
| |
|
|
| |
|
Interrelationships Between Cyclooxygenases and Aromatase: Unraveling the Relevance of Cyclooxygenase Inhibitors in Breast Cancer
|
| |
|
pp.221-232 (12) Authors: Edgar S. Diaz-Cruz, Robert W. Brueggemeier |
| |
|
|
| |
|
The Use of Nimesulide and Its Analogues in Cancer Chemoprevention
|
| |
|
pp.233-237 (5) Authors: Jean-Francois Renard, Fabien Julemont, Xavier d. Leval, Bernard Pirotte |
| |
|
|
| |
|
A Computational View of COX-2 Inhibition
|
| |
|
pp.239-249 (11) Authors: Philippe Chavatte, Amaury Farce |
| |
|
|
| |
|
Promotion of Optimized Protein Therapy by Bioconjugation as a Polymeric DDS
|
| |
|
pp.251-258 (8) Authors: Yasuhiro Abe, Hiroko Shibata, Haruhiko Kamada, Shin-Ichi Tsunoda, Yasuo Tsutsumi, Shinsaku Nakagawa |
| |
|
|
| |
|
Biological Effects of Curcumin and Its Role in Cancer Chemoprevention and Therapy
|
| |
|
pp.259-270 (12) Authors: Sarvjeet Singh, Ashok Khar |
| |
|
|
| |
|
Betulinic Acid Derivatives as Anticancer Agents: Structure Activity Relationship
|
| |
|
pp.271-279 (9) Authors: Rama Mukherjee, Vivek Kumar, Sanjay K. Srivastava, Shiv K. Agarwal, Anand C. Burman |
| |
|
|
